Biomx Inc (PHGE)

Name: Biomx Inc (PHGE) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Biomx Inc (PHGE)

Stock Card

$0.14

$-0.68 (-83.06%)

As on 28-Aug-2026 16:23EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

26.8

Div. Yield

0 %

Biomx Inc (PHGE) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.13 High: 0.15

52 Week Range

Low: 0.13 High: 105.12

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.2
Debt to Equity

0
Book Value

$--
EPS

$-0
Face value

--
Shares outstanding

26,559,607

8 Years Aggregate

CFO

$-136.72 Mln

EBITDA

$-147.81 Mln

Net Profit

$-160.82 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Biomx Inc (PHGE)	-92.6	--	-83.1	-98.7	-87.7	-82.1	--
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020
Biomx Inc (PHGE)	-86.5	-73.6	49.7	-88.3	-74.9	-34.1
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Biomx Inc (PHGE)	0.1	3.7	0.3	-41.6	-7,098.5	--	--	26.8
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	144.3	9,339.4	282.0	82.9	-28.6	11.4	140.1	11.5

Shareholding Pattern

View Details

About Biomx Inc (PHGE)

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security,... wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware. Read more

CEO & Director

Mr. Jonathan Eitan Solomon MBA
Scientific Founder

Prof. Rotem Sorek Ph.D.
Headquarters

Dover, DE
Website

https://www.biomx.com

FAQs for Biomx Inc (PHGE)

What is the current share price of Biomx Inc (PHGE) Today?

The share price of Biomx Inc (PHGE) is $0.14 (NYSE) as of 28-Aug-2026 16:23 EDT. Biomx Inc (PHGE) has given a return of -87.68% in the last 3 years.

What is the current PB & PE ratio of Biomx Inc (PHGE)?

Since, TTM earnings of Biomx Inc (PHGE) is negative, P/E ratio is not available.
The P/B ratio of Biomx Inc (PHGE) is 26.81 times as on 21-Aug-2026, a 418 premium to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.